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University of Graz, Institute of Biophysics, Graz, AustriaABSTRACT Atrial fibrillation (AF), the most common arrhythmia in humans, is initiated when triggered activity from the pulmo-
nary veins propagates into atrial tissue and degrades into reentrant activity. Although experimental and clinical findings show a
correlation between atrial fibrosis and AF, the causal relationship between the two remains elusive. This study used an array of
3D computational models with different representations of fibrosis based on a patient-specific atrial geometry with accurate
fibrotic distribution to determine the mechanisms by which fibrosis underlies the degradation of a pulmonary vein ectopic
beat into AF. Fibrotic lesions in models were represented with combinations of: gap junction remodeling; collagen deposition;
and myofibroblast proliferation with electrotonic or paracrine effects on neighboring myocytes. The study found that the occur-
rence of gap junction remodeling and the subsequent conduction slowing in the fibrotic lesions was a necessary but not sufficient
condition for AF development, whereas myofibroblast proliferation and the subsequent electrophysiological effect on neigh-
boring myocytes within the fibrotic lesions was the sufficient condition necessary for reentry formation. Collagen did not alter
the arrhythmogenic outcome resulting from the other fibrosis components. Reentrant circuits formed throughout the noncontig-
uous fibrotic lesions, without anchoring to a specific fibrotic lesion.INTRODUCTIONAtrial fibrillation (AF) is the most common cardiac
arrhythmia associated with patient morbidity and mortality,
affecting over two million people in the United States alone
(1). AF is initiated when triggered activity from the pulmo-
nary veins (PVs) propagates into atrial tissue and, via mech-
anisms incompletely understood, degrades into reentrant
activity (2). Catheter ablation, including the electrical isola-
tion of PVs to prevent ectopic signal propagation into atrial
chambers, has emerged as a promising treatment strategy for
patients who suffer from AF. However, overall success rates
for terminating AF via catheter ablation are low, with recent
surveys reporting only 70% success (3). Advancements in
catheter ablation procedures are hindered by the elusive na-
ture of the mechanisms underlying AF.
Recent clinical and experimental studies have convinc-
ingly demonstrated a correlation between atrial fibrosis
and AF. Atrial biopsies from paroxysmal AF patients
show increased interstitial fibrosis compared to sinus
rhythm control subjects (4). Studies of explanted human
hearts demonstrate that atrial collagen volume correlates
positively with AF persistence when comparing nonarrhyth-
mic individuals to those who suffer permanent and per-
sistent AF (5). Furthermore, atrial fibrosis has been
documented in patients who develop postoperative AF (6).
In a study in which late gadolinium-enhanced magnetic
resonance imaging (LGE-MRI) was used before ablationSubmitted March 8, 2013, and accepted for publication May 10, 2013.
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wall, it was found that an increased amount of LA fibrosis
is strongly associated with AF recurrence after catheter
ablation (7). Although these findings convincingly show a
correlation between atrial fibrosis and AF, the causal rela-
tionship between fibrosis and AF remains incompletely
understood.
Fibrotic remodeling of atrial tissue involves processes
that occur in parallel across multiple scales. Gap junction re-
modeling (GJR) at the membrane level (8), fibroblast pheno-
type switching at the cellular level (9), and the deposition of
excess collagen at the tissue level (5) give rise to complex
interactions at the organ level, setting the stage for AF initi-
ation in the fibrotic atria. In addition, studies also indicate
that the extent and distribution of fibrotic lesions within
the human LA, the quantification of which has recently
been made possible by improved MRI technology, may
also contribute mechanistically to AF susceptibility (10).
Given the complex and interdependent nature of the remod-
eling processes involved in fibrosis, compounded by its het-
erogeneous distribution throughout the human atrium,
isolating the unique mechanisms by which fibrosis and its
components contribute to human AF is difficult to achieve
experimentally. However, the ability to obtain high-resolu-
tion images in vivo that capture both patient atrial geometry
and fibrotic distribution makes it possible to reconstruct pa-
tient-specific LA geometries with accurate fibrotic lesion
morphology (11). A computational model with accurate rep-
resentation of atrial geometry and fibrotic lesion distribution
presents a powerful tool to explore how fibrotic remodelinghttp://dx.doi.org/10.1016/j.bpj.2013.05.025
Mechanistic Study of Fibrosis in AF 2765at the membrane, cellular, and tissue-level give rise to an ar-
rhythmogenic substrate at the organ level.
The goal of this study was to determine the mechanisms
by which fibrosis in the human atria underlies the degrada-
tion of a PV ectopic beat into AF. To achieve this goal, we
used a realistic model of atrial fibrosis distribution generated
from high-resolution LGE-MRI images acquired in vivo
from a patient suffering from persistent AF. Modeling the
fibrotic lesions incorporated representations of collagen
deposition, GJR, and myofibroblast proliferation. Simula-
tions with eight different atrial fibrosis models developed
from the baseline LA geometric model were performed to
determine how each component of fibrotic remodeling as
well as their combinations contributes to the arrhythmo-
genic substrate.METHODS
Detailed Methods are available in the online Supporting Material. Briefly, a
patient with persistent AF presenting for catheter ablation underwent LGE-
MRI acquisition (12); a representative slice of the MR image stack is shown
in Fig. 1. Image segmentation and interpolation resulted in a high-resolu-
tion image of the atrial wall with extensive fibrotic lesions (Fig. 1); the
fibrotic lesion size and distribution in this patient was typical for patients
with extensive fibrosis in the LA and persistent AF (12). We chose to model
only the LA based on the fact that 94% of ectopic beats that result in AF
initiation originate in the PVs (2) and 76% of AF sources (among which
electrical rotors) were found to be located in the LA (13). A finite elementFIGURE 1 Model generation. Representative MRI slice of the human
heart, segmentation of the atrial tissue, and construction of the 3D atrial
model.tetrahedral mesh was generated from the segmented image stack, and fiber
orientation was incorporated as previously described (11,14) (see the Sup-
porting Material). Nonfibrotic regions of the tissue were represented with a
modified version of the Courtemanche et al. (15) model of the human atrial
action potential under AF conditions, as described by Krummen et al. (16);
the model also included the formulation of the acetylcholine-activated po-
tassium current, IK(ACh), fromKneller et al. (17) Conductivities were chosen
such that conduction velocity fell within the range recorded in the human
atrium (18); additional details can be found in the Supporting Material.Modeling fibrotic tissue
Atrial fibrosis is characterized by numerous pathophysiological processes:
1), a progressive thickening of the interstitial matrix, including diffuse
collagen deposition and subsequent separation of individual myocytes; 2),
GJR due to connexin 43 (Cx43) protein downregulation and lateralization;
and 3), fibroblast proliferation and phenotype switching into myofibro-
blasts. Although these aspects of remodeling progress simultaneously, it
is useful to separate the different fibrotic manifestations to isolate and inves-
tigate their unique contributions to the arrhythmogenic substrate. For this
reason, eight distinct atrial models were generated for the study, based on
the original atrial geometry and fibrotic lesion distribution, but each with
a unique representation of one or more components of fibrosis (see Table
1, left column). One control model was constructed, in which no fibrotic
structural remodeling was included in the atrium (i.e., the fibrotic lesions
were assumed to have the properties of nonfibrotic atrial myocardium).
Three models, each with one of the previous components of fibrosis (diffuse
collagen deposition, GJR, or myofibroblast proliferation with coupling to
myocytes) in the fibrotic lesions were developed. Additionally, three
models, each with a combination of two of the previous components in
the fibrotic lesions, were generated. Finally, one model that included all
three of the previous characteristics in the fibrotic lesions was constructed.
Detailed descriptions of the model representations of each of the three com-
ponents of fibrosis are found below. All fibrotic remodeling was confined to
the patient-specific fibrotic lesions, i.e., the red regions in Fig. 1.
Under AF (5), collagen deposition in the LA is upregulated and typically
presents diffuse architecture (i.e., is parallel to muscle bundles). To repre-
sent this diffuse collagen deposition in the fibrotic lesions, we employed
a method of 3D decoupling of the finite elements in the model that corre-
spond to fibrotic lesions, as described in the SupportingMaterial, thus simu-
lating the fine conduction barriers introduced by collagen along the fiber
direction. This method was first developed in 2D by Costa el al. (19), and
we have recently extended the technique to 3D (11). Additional simulations
were performed to test the implications of patchy collagen (i.e., collagen
that is both parallel and transverse to muscle bundles), because evidence ex-
ists suggesting that this architecture may also be present in the fibrotic
atrium in AF (20). Patchy collagen was represented as passive insulators in-
terrupting both transverse and longitudinal connections between cells, asTABLE 1 Outcome of PV ectopy in the LA models with





Collagen deposition (patchy or diffuse) P P
Myofibroblast coupling P P
GJR & collagen deposition (patchy or diffuse) U P
Collagenous deposition (patchy or diffuse)
& myofibroblast coupling
P P
GJR & myofibroblast coupling U U
GRJ, collagenous deposition (patchy or diffuse),
& myofibroblast coupling
U U
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patchy collagen deposition, 1% and 10% collagen by volume were
randomly distributed throughout the fibrotic regions. These densities
were based on experimental data for the human LA under AF, where up
to 7% collagen by volume was documented, when considering both
collagen types I and III (5).
A study examining atrial substrates in patients with AF found that the
more collagen deposited in each substrate, the less Cx43 expressed (24);
the overall reduction of Cx43 volume fraction observed in atria in chronic
AF compared to sinus rhythm was found to be ~30%. Likewise, atrial
biopsies from human patients with AF exhibited Cx43 lateralization (8)
rather than localization at the intercalated discs; lateral Cx43 labeling (as
a percentage of the total amount of Cx43 per myocyte) was found to be
3.9-fold higher in atrial free wall myocytes in the AF group compared to
sinus rhythm. To represent this GJR, myocardial conductivity values in
the fibrotic lesions of the model were decreased by 53% in the longitudinal
direction and increased by 2.5-fold in the transverse direction, compared to
the nonfibrotic conductivities in the remainder of the atria (11), thus
achieving a 30% reduction in combined conductivity (as measured by Cx
protein expression quantification methods) and a 3.9-fold increase in the ra-
tio of transverse/combined conductivity.
Finally, myofibroblast properties were randomly assigned to 1% of the
fibrotic lesions to represent the myofibroblast proliferation observed exper-
imentally under fibrosis conditions (25). Myofibroblasts were electrically
connected to adjacent myocytes, as observed experimentally (26), and
membrane kinetics was modeled following our previously published meth-
odology (11,27).Simulation protocol and data analysis
Mathematical description of current flow was based on the monodomain
representation of the myocardium and simulations were executed using
the simulation package CARP (CardioSolv LLC) (28). To test the arrhyth-
mogenic propensity of the atrial models with different fibrotic representa-
tions, each substrate was paced for 5 beats at 365 ms cycle length,
followed by two premature beats (S2 and S3) at cycle lengths ranging
from 230 to 260 ms. Preliminary studies identified this pacing sequence
as the most computationally efficient protocol to initiate AF; extending
the stimulus protocol did not alter arrhythmia outcomes. Stimulus location
was also chosen after preliminary results indicated that pacing from various
locations in the PVs resulted in the formation of identical AF rotors, indi-
cating that the substrate (and not pacing location) determined rotor location.
Therefore, a single stimulus site was used for this study, located between the
left superior and inferior PVs (Fig. 2, red dot, at top left). The initiation of
reentrant arrhythmia was defined as the occurrence of unidirectional block
and subsequent formation of a reentrant circuit following the premature
beats. The formation of a reentrant circuit was assumed to mark the initia-
tion of AF due to recent evidence that localized rotors or focal impulses are
detected in 97% of patients with sustained AF (13).
To delineate how the various components of fibrosis differentially
contribute to arrhythmia propensity in the fibrotic atria, each substrate
was analyzed in several ways:
1. To assess the influence of the fibrotic components on conduction, activa-
tion maps were constructed for each atrial model. Activation time was
considered to be the time between S2 stimulus and local time of excita-
tion, defined as the time at which transmembrane potential exceeded a
threshold of 20 mV.
2. Myofibroblasts have a less negative resting membrane potential (VREST)
than myocytes, and thus can cause diastolic depolarization in myocytes
with which they electrically couple. Indeed, research has shown that car-
diomyocytes exhibit a myofibroblast density-dependent gradual depolar-
ization when coated with myofibroblasts (29). Thus, maps of VRESTwere
generated for each atrial model to characterize the spatial distribution of
diastolic potential and analyze its effect on conduction.Biophysical Journal 104(12) 2764–27733. Experimental evidence suggests that myofibroblasts can alter the action
potential duration (APD) of myocytes with which they electrically
couple (30). At the tissue level, APD dispersion can increase the suscep-
tibility of the substrate to arrhythmia (31). Therefore, APD maps for
each atrial model were generated by calculating the local durations
from peak action potential amplitude to 90% repolarization.RESULTS
Effects of atrial fibrosis on propensity to
arrhythmia
Propensity to arrhythmia following premature (ectopic)
beats in the PVs was assessed in each of the eight models;
events such as occurrence of conduction block and subse-
quent reentry are summarized in Table 1. Neither unidirec-
tional block nor reentry occurred in the control (i.e.,
nonfibrotic) case. Conduction block took place in all models
that incorporated GJR in the fibrotic regions. The inclusion
of diffuse collagen deposition or myofibroblasts (in combi-
nation or alone) in the fibrotic regions did not result in
conduction block following ectopic wave propagation.
However, when either of these components of fibrosis was
combined with GJR in the fibrotic lesions, conduction block
ensued. Likewise, in the scenario in which all three fibrosis
characteristics were modeled, block was observed. There-
fore, this study found that the remodeling of gap junctions
in fibrotic lesions was the primary contributor to conduction
block following PVectopy in the atrium, and the addition of
other components of fibrosis did not suppress the occurrence
of conduction block. When collagen of patchy architecture
was incorporated at densities of 1% and 10% by volume
(instead of diffuse collagen), arrhythmia outcomes were
identical to those resulting from diffuse collagen, as pre-
sented in Table 1.
The formation of reentry is contingent upon first the
occurrence of block, but does not arise in all cases of block.
Of the four scenarios in which conduction block occurred
(fibrotic lesions modeled with GJR alone; GJR and
collagen deposition, GJR and myofibroblasts coupled to
myocytes, and GJR with both myofibroblasts and collagen
deposition), only the latter two (i.e., models that repre-
sented myofibroblasts coupled to myocytes in the fibrotic
lesions) resulted in reentry. In both of these cases, the reen-
trant circuit subsequently degraded into sustained AF that
lasted for at least 15 s (the maximum computationally prac-
tical time tested). GJR in the fibrotic lesions alone did not
support the formation of a reentrant circuit, and the pres-
ence of patchy or diffuse collagen had no effect on the sub-
strate’s propensity to arrhythmia in any of the models.
Thus, our simulation results indicate that the presence of
myofibroblasts coupled to myocytes is the critical condition
for reentry formation following conduction block in the
fibrotic atrium. The addition of other components of
fibrotic remodeling did not alter the substrate’s ability to
form a reentrant circuit.
FIGURE 2 Transmembrane potential maps at three time instants in three atrial models with different arrhythmogenic outcomes: neither conduction block
takes place nor reentry is established (leftmost column; exclusively diffuse collagen deposition modeled in the fibrotic lesions); conduction block occurs
without the formation of a reentrant circuit (middle column; GJR and diffuse collagen deposition included in the fibrotic lesions), and both conduction block
and reentry occur, initiating AF (rightmost column; GJR, diffuse collagen deposition, and myofibroblasts coupled to myocytes included in fibrotic lesions).
Lines of block are marked in red. Black arrows indicate direction of propagation. Fibrotic distribution is pictured at bottom right, with anatomical labels for
the LA appendage (LAA), right superior PV (RSPV), right inferior PV (RIPV), left superior PV (LSPV), and left inferior PV (LIPV).
Mechanistic Study of Fibrosis in AF 2767Fig. 2 presents a summary of the three possible outcomes
following a PV ectopic propagation (with conduction path-
ways shown): neither conduction block nor reentry is estab-
lished (leftmost column; exclusively diffuse collagen
deposition is modeled in the fibrotic lesions); conduction
block occurs without the formation of a reentrant circuit
(middle column; GJR and diffuse collagen deposition are
included in the fibrotic lesions in the case presented in the
figure); and both conduction block and reentry occur to
initiate AF (rightmost column; GJR, diffuse collagen depo-
sition, and myofibroblasts coupled to myocytes are included
in the fibrotic lesions in the model shown). Other combina-
tions of fibrosis components not included in Fig. 2 exhibitedconduction patterns similar to those pictured for the corre-
sponding PV ectopy outcome.Mechanism for conduction block in fibrotic
lesions
The electrophysiological properties of substrates that ex-
hibited conduction block following ectopic beats (i.e., atrial
models with GJR in fibrotic regions) were compared to
those of substrates that were not susceptible to conduction
block (i.e., atrial models without GJR in the fibrotic re-
gions). Slowed conduction and discontinuous propagation
were observed in all models that experienced conductionBiophysical Journal 104(12) 2764–2773
2768 McDowell et al.block. To illustrate this finding, activation maps following a
premature beat from the left PVs of select substrates are dis-
played in Fig. 3. Activation times following a premature
beat are longer than those in sinus rhythm or following
slower pacing rates due to the steep conduction velocity
restitution experienced by patients who suffer from AF
(32); AF patients show a conduction slowing of ~48%
with rate acceleration (33).
In a substrate with only collagen distribution (diffuse or
patchy) incorporated into the fibrotic lesions (left-most
substrate in Fig. 3), conduction propagated in a fairly
smooth and continuous manner, as indicated by the uniform
and concentric activation pattern. The collagen deposition
did not disrupt conduction in the model. This finding is sup-
ported by the experimental evidence that collagen of diffuse
architecture (as often found in human atria (5,34)) has a
minimal effect on conduction delay, even at high densities
(35). Furthermore, although patchy collagen architecture
at higher densities has been shown to affect conduction in
the ventricles (35), existing experimental data do not indi-
cate that the density (up to 7%) (5) of collagen of patchy ar-
chitecture found in the human LA under AF contributes to
conduction abnormalities.
In the substrate that contained only myofibroblasts
coupled to myocytes as a representation of fibrosis (2nd
from left substrate in Fig. 3), conduction through tissue pro-
ceeded discontinuously (with jagged isochrones) as it tra-
versed more slowly through fibrotic lesions than through
nonfibrotic tissue, although total LA activation time was
only 5 ms longer than control. Myofibroblasts were the
culprit of this slowing of conduction within fibrotic lesions,
because they caused VREST elevation in myocytes with
which they were electrically coupled (29), resulting in par-
tial sodium channel inactivation. Indeed, as indicated in
Fig. 4 A, a myocyte within a fibrotic lesion experienced an
elevated VREST of 74.5 mV, compared to VREST of
78mV within a lesion but without myofibroblasts. At the
organ level, distribution of VREST elevation in substrates
with electrically coupled myofibroblasts (see Fig. 4 C,
bottom row) followed the pattern of fibrotic lesion distribu-
tion (as pictured in Fig. 2). When myofibroblasts were ab-
sent from the substrate (Fig. 4 C, top row), VREST
distribution was uniform, and the corresponding activation
maps had smooth isochrones.Biophysical Journal 104(12) 2764–2773The substrate with only GJR in the fibrotic lesions (2nd
from right substrate in Fig. 3) exhibited a similar trend of
discontinuous wave propagation, resulting in jagged activa-
tion isochrones, and due again to slower conduction
through fibrotic lesions. However, total LA activation
time was 38 ms longer than in the control case. Thus,
GJR in the fibrotic lesions caused a much larger degree
of conduction slowing (total LA activation time increased
by 12%) compared to that caused by myofibroblasts infil-
tration in the fibrotic lesions and their coupling to myo-
cytes (total LA activation time increased by only 2%).
Because PV ectopy in substrates with GJR resulted in con-
duction block, whereas those with only myofibroblasts did
not, it follows that a large degree of conduction slowing (at
least >5 ms) is necessary to support conduction block
following PV ectopy in the LA. When lower values of
GJR were tested and conduction slowing of 5 ms was not
achieved, conduction block did not occur. When conduc-
tion was sufficiently slowed (i.e., in substrates with the
GJR represented as described in the Methods section),
the S3-induced wavefront encountered tissue that was
both fully recovered (nonfibrotic regions), and in a refrac-
tory state (fibrotic lesions). Indeed, the red lines of conduc-
tion block in Fig. 2 correspond to the border of a densely
fibrotic lesion (as seen in the fibrotic lesion distribution
in Fig. 2).Mechanism for reentry formation following
conduction block in fibrotic lesions
The electrophysiological properties of the substrates in
which a reentrant circuit resulted from PVectopy, following
conduction block, and degraded into sustained AF (i.e.,
atrial models with GJR and electrically coupled myofibro-
blasts in the fibrotic lesions) were compared to those of sub-
strates that did not promote reentry despite the occurrence of
conduction block (i.e., atrial models with GJR but without
myofibroblasts in the fibrotic lesions) to determine the
mechanisms by which myofibroblast presence and their
coupling to myocytes rendered the fibrotic substrate arrhyth-
mogenic. We investigated this by assessing the alterations in
local action potential morphology (Fig. 4, A and B), as well
as in organ-level electrophysiological behavior (Fig. 4, C
and D).FIGURE 3 Activation maps in four atrial
models, with fibrotic lesions modeled with (from
left to right) diffuse collagen deposition, myofibro-
blast coupling, GJR, and the combination of GJR
and diffuse collagen deposition.
FIGURE 4 (A) Action potential waveforms of myocytes within homocellular (i.e., myocyte only) and heterocellular (i.e., with electrically coupled my-
ofibroblasts and myocytes) fibrotic lesions. (B) Difference in transmembrane potential between the two action potential waveforms of myocytes within a
fibrotic lesion (homocellular lesion myocyte – heterocellular lesion myocyte), from the action potential notch to 90% repolarization. Maps of VREST (C)
and APD (D) in four models. Fibrotic lesions are modeled with (bottom row) and without (top row) myofibroblast infiltration (and coupling to myocytes),
as well as with (right column) and without (left column) diffuse collagen deposition for both sets of maps. All models include GJR in the fibrotic lesions.
Mechanistic Study of Fibrosis in AF 2769Although myofibroblasts are inexcitable cells, they can
alter action potential morphology of atrial myocytes with
which they are coupled (36). Fig. 4 A shows how the trans-
membrane potential of a myocyte within a fibrotic lesion
composed of an electrically connected network of myocytes
and myofibroblasts (heterocellular lesion) compared to that
of a myocyte within a fibrotic lesion with only other myo-
cytes (homocellular lesion). Although the depolarization
phase of the action potential remains relatively unaltered be-
tween the two waveforms, myofibroblasts exerted a clear in-
fluence on myocyte repolarization dynamics. The difference
in transmembrane potential between the two waveforms
(homocellular lesion myocyte – heterocellular lesion myo-
cyte), from the action potential’s notch to 90% repolariza-
tion is quantified in Fig. 4 B. A myocyte within a
heterocellular lesion experiences reduced peak amplitude
and reduced transmembrane potential at the onset of repo-
larization compared to a myocyte within a homocellular
lesion. The degree of the transmembrane potential reduction
changes over the course of repolarization, as illustrated by
Fig. 4 B. As repolarization approaches 90%, a crossover
of the action potential waveforms occur (Fig. 4 A), due tothe elevated resting potential of the myocyte in the hetero-
cellular lesion. At 90% repolarization, APD is shorter in
myocytes within heterocellular lesions. Indeed, APD distri-
bution at the organ level exhibits shortening in myofibro-
blast-infiltrated fibrotic lesions (Fig. 4 D, bottom row, and
compare to Fig. 4 D, top row). Although an average APD
of 219 ms was calculated across the LA without myofibro-
blasts in the fibrotic lesions, the average APD was 181 ms
in substrates incorporating myofibroblasts in the lesions.
Introducing diffuse collagen deposition into myofibro-
blast-infiltrated fibrotic lesions (Fig. 4 D, bottom right
compared to bottom left) exacerbated the APD shortening
caused by myofibroblasts; APD decreased to 130 ms in
densely fibrotic regions. This effect is because collagen,
which interrupts connections between cells, limits the dis-
tance over which myofibroblasts can exert an electrotonic
influence; myofibroblasts, therefore, act as a greater local
current sink when collagen is present. This also explains
why collagen deposition did not alter APD in substrates
without myofibroblasts (Fig. 4 D, top right compared to
top left). The additional APD shortening caused by the in-
clusion of collagen deposition (diffuse or patchy) in theBiophysical Journal 104(12) 2764–2773
2770 McDowell et al.fibrotic lesions was insufficient to alter the arrhythmogenic
propensity of the substrates (Table 1).
Although functional coupling between myofibroblasts
and myocytes is well established in the cell culture setting,
direct evidence of functional gap junction formation be-
tween myofibroblasts and myocytes in the intact working
myocardium is limited, having only been demonstrated in
the sinoatrial node (26). However, myofibroblasts could
also affect neighboring myocytes via paracrine influences.
Indeed, paracrine factors released by fibroblasts have been
shown to alter myocyte repolarization currents, and it has
been hypothesized that these factors may contribute to the
arrhythmogenic behavior of fibrotic substrates (30,37).
Because the results presented herein suggest that myofibro-
blast-myocyte coupling alters repolarization dynamics to
support reentry, we sought to determine whether direct
changes in repolarization currents, as arising from paracrine
effects, could also support reentrant circuit formation. Our
simulation results show that atrial models in which myofi-
broblasts in the fibrotic lesions did not couple electrically
to myocytes could also support reentry formation. This
occurred when potassium currents in myocytes within the
fibrotic lesions were altered. Fig. 5 presents a set of mini-
mum paracrine alterations in the four potassium currents
that was determined necessary to establish reentry forma-
tion in fibrotic models with myofibroblast proliferation but
without electrical coupling to neighboring myocytes: the in-
ward rectifier Kþ current (IK1), the acetylcholine-activated
Kþ current, IK(ACh), the rapid delayed rectifier K
þ current
(IKr), and the slow delayed rectifier K
þ current (IKs). With
these paracrine effects represented in the atrial model, sus-
tained AF also ensued following PV ectopic beats; a snap-
shot of atrial activity encompassing multiple wavefronts is
shown in Fig. 5.DISCUSSION AND CONCLUSION
In this study, we sought to determine the mechanisms by
which fibrosis and its components contribute to the degra-Biophysical Journal 104(12) 2764–2773dation of PV ectopic beats into AF in the human atria. To
achieve this, we used a 3D model of a patient-specific LA
from a subject suffering persistent AF, capturing accurately
both the atrial geometry and the distribution of fibrotic le-
sions. Simulations were conducted on an array of models
of the same geometry/fibrosis distribution but whereby the
fibrotic lesions were represented with combinations of
GJR, collagen deposition, and myofibroblast proliferation,
and where myofibroblasts either coupled electrically with
myocytes in the fibrotic lesions or exerted equivalent para-
crine influences on them. The study found that for fibrotic
lesions typical of human remodeled atria under the condi-
tions of persistent AF, the occurrence of GJR in the fibrotic
lesions was a necessary but not sufficient condition for the
development of AF following a PV ectopic beat. The suffi-
cient condition was myofibroblast proliferation in these le-
sions, where myofibroblasts exerted either electrotonic or
paracrine influences on myocytes within the lesions. Depo-
sition of collagen in the lesions, modeled as a diffuse or
patchy distribution based on experimental data, was neither
a necessary nor a sufficient condition for AF development,
however, it assisted the myofibroblasts’ paracrine or elec-
trotonic effects by additionally shortening APD in the
lesions.
Representing the distribution of fibrotic lesions as it oc-
curs in the human atria under the conditions of persistent
AF was essential for uncovering the specific relation be-
tween atrial fibrosis and AF in the human. Atrial LGE-
MRI scans from other patients with extensive enhancement
exhibit similar trends in fibrotic lesion distribution (12),
lacking large contiguous regions of remodeled (fibrotic) tis-
sue—instead, the fibrotic lesions are unevenly distributed in
a noncontiguous fashion throughout the LA anterior wall,
posterior wall, and the atrial septum. Although reentry
development in the ventricles occurs under the conditions
of myocardial infarction where a large fairly contiguous re-
gion of fibrotic scar and associated peri-infarct zone both
anchor the reentrant arrhythmia and determine its anatomic
pathway (38), the reentrant circuits associated with AF inFIGURE 5 (A) Densities of ion currents as a
function of time for a myocyte with and without
an electrically coupled myofibroblast. Should para-
crine effects occur, alterations in ion channel cur-
rents need to amount to these changes for
reentrant circuit formation to occur without myofi-
broblast-to-myocyte electrical coupling. (B) Snap-
shot of AF activity in an atrial model where
paracrine effects are represented in the fibrotic le-
sions (i.e., when potassium currents in fibrotic le-
sions were altered to mimic the changes that
occur due to myofibroblast coupling).
Mechanistic Study of Fibrosis in AF 2771the fibrotic atrium freely traverse the fibrotic regions
without being anchored to any specific lesion.
This study presents a novel, to our knowledge, model of
human atrial fibrosis under the conditions of persistent AF
in a patient-specific representation of the atrial geometry
and structure. Previous studies of fibrosis and its arrhythmo-
genic propensity have modeled fibrotic remodeling either by
slowing conduction uniformly throughout the tissue (39) or
by including only single elements of fibrosis modeled in a
simplified manner, such as only fibroblasts modeled as pas-
sive resistors (40) or only collagen modeled as holes in the
tissue (41). Furthermore, previous modeling efforts did not
incorporate the realistic nonuniform distribution of fibrosis
in the substrate (39). In contrast, our realistic model of hu-
man atrial fibrosis allows for the thorough exploration of
the role of different elements of fibrotic remodeling in
persistent AF.
Our finding that GJR occurrence and the resulting slowed
conduction within the fibrotic lesions contributes to AF is
supported by experimental evidence. When congestive heart
failure, a disease strongly associated with clinical AF, was
induced in dog hearts, it was found to result in discrete re-
gions of slowed conduction and increased fibrosis compared
to control (42). Furthermore, a recent study in porcine atria
documented a correlation between regional Cx43 expres-
sion and sites where complex fractionated atrial electro-
grams (CFAE) were recorded; the expression of Cx43 at
CFAE sites was significantly decreased when compared
with nonCFAE sites (43).
A major finding in this study is that myofibroblast prolif-
eration plays a key role in AF pathogenesis. Existing
experimental evidence supports this finding. For one, atrial
fibroblasts have a greater tendency to differentiate into
activated myofibroblasts both in vitro and in vivo compared
to ventricular fibroblasts (44), one explanation for why
atria exhibit a more sensitive fibrotic response than ventri-
cles in disease progression (45). Furthermore, a recent
study has reported novel insights into the role of the fibro-
blast as the cellular link between AF and atrial fibrosis
(46). In this study, it was found that transient receptor
potential canonical-3 (TRPC3) channels in fibroblasts regu-
late cell proliferation and differentiation into myofibro-
blasts. The study showed that AF increases TRPC3
expression, and that TRPC3 blockade prevents AF
substrate development in a dog model of electrically main-
tained AF, providing direct evidence of the myofibroblasts’
critical role in AF. Evidence also suggests that myofibro-
blasts may influence the electrophysiological substrate
directly through either electrical coupling with myocytes
(29,47) (which has been observed in rabbit sinoatrial
node (26)), or via paracrine factors (30,37). Experimental
recordings from myocytes in fibroblast-conditioned media
further support our findings that altered potassium currents
due to myofibroblast paracrine factors may contribute to ar-
rhythmogenesis (37).Considerable evidence exists suggesting a correlation be-
tween AF incidence and increased collagen (5), and it has
thus been hypothesized that collagen contributes to arrhyth-
mogenesis in the fibrotic substrate. However, in a study in
which Cx43 expression was similar in young and old
mice, increased collagen content in adult mice was not suf-
ficient to promote arrhythmia inducibility (48). It has also
been reported that both the density and the architecture of
collagen play an important role in determining its electrical
influence (35). In ventricular disease progressions or in an-
imal models in which patchy or stringy collagen may exist
at higher densities, collagen was found to likely contribute
to arrhythmogenesis (35). Our results did not indicate a crit-
ical role of collagen deposition in human AF initiation
following PV ectopy, but that collagen deposition did not
alter the arrhythmogenic outcome resulting from other
fibrotic components present in the substrate, consistent
with previous simulation findings (21) and with the results
of a canine study of spiral wave behavior (49). It is possible
that the amount of collagen correlates with AF incidence not
because of its mechanistic role in arrhythmogenesis, but
because increased deposition occurs as a side effect of fibro-
blast proliferation and differentiation, both of which may be
triggered by AF itself (46), or even by GJR (50).
The insights gained in this study regarding atrial fibrosis
and its relation to AF shed important light on the reasons
why approaches such as Cx gene transfer (51), APD prolon-
gation (52), and TRPC3 channel blockade (46) prevent AF
in animal studies. Furthermore, by dissecting out the mech-
anisms by which fibrosis leads to a generation of AF
following PV ectopy the study may open new doors for
the development of therapeutic targets aimed at AF termina-
tion. Given the critical importance of the electrical influence
of myofibroblasts in establishing an arrhythmogenic sub-
strate, therapies that target the intercellular communication
between myofibroblasts and myocytes or that block the dif-
ferentiation of fibroblasts into myofibroblasts present viable
upstream targets.Limitations
The distinction between an activated fibroblast and myofi-
broblast is blurred throughout literature (53), and many
studies concerned with one phenotype use data from the
other phenotype to support their findings (54,55). The fact
that fibroblasts plated under standard conditions (at low den-
sity and in serum) begin expressing the myofibroblast
marker (a-SMA) within 1–2 days following isolation (56)
forces us to question whether fibroblast studies in cell cul-
ture systems were, in actuality, myofibroblast studies all
along (57). Although this study assumes that the myofibro-
blast phenotype forms under pathological conditions, it is
possible that the electrical connections arising from acti-
vated fibroblasts, which may also electrically couple with
myocytes or exert paracrine influences, could contribute toBiophysical Journal 104(12) 2764–2773
2772 McDowell et al.arrhythmogenesis by similar mechanisms to those we pro-
pose here.
The human atrial model of fibrosis used in this study rep-
resents the atrium of one human patient with a unique distri-
bution of fibrosis; models reconstructed from other patients
would be different in both geometry and specific fibrosis
distribution. However, at this point, there are practical lim-
itations to the generation of numerous patient-specific
meshes due to the high resolution of the clinical LGE-
MRI scans required to create a high quality computational
mesh of the human atria. As clinical MRI resolution im-
proves, we expect that the generation of such models will
become routine in the near future. However, because the
fibrotic lesion size and distribution in this patient was
typical for patients with extensive fibrosis in the LA and
persistent AF (12), we do not expect that the conclusions
regarding the roles of various components of fibrosis in ar-
rhythmogenesis will change with different patient-specific
models of the fibrotic atria.
Nonfibrotic tissue properties were modeled based on
experimental findings of ion channel remodeling under AF
conditions (58). However, many of the underlying pathol-
ogies that lead to persistent AF can also cause changes in
ion channel properties, separate from those induced by AF
(59). Further study of the effects of such changes is
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